慢性硬膜下血肿的手术治疗与转归:埃塞俄比亚与挪威的比较研究
比较埃塞俄比亚与挪威慢性硬膜下血肿患者的人口学、治疗与转归差异。埃塞俄比亚前瞻性纳入314例,挪威回顾性纳入284例,均以局部麻醉下钻孔引流加术后引流为标准术式。挪威患者年龄更大、合并症及抗凝/抗血小板药物使用更多,并发症与再手术率更高,1年死亡率7%对3.5%,末次随访GOSE 8分比例46.8%对82.9%。
要点
- 两国标准术式均为局部麻醉下钻孔颅骨钻孔术加术后引流。
- 挪威患者年龄更大、合并症及抗凝/抗血小板使用更多,再手术与内科并发症更常见。
- 末次随访(>3年)GOSE 8分比例埃塞俄比亚82.9%高于挪威46.8%。
核心结论
- 两国手术治疗方式相似,挪威转归较差很大程度上可由年龄、合并症、用药和并发症率解释。
研究设计与样本
- 纳入亚的斯亚贝巴大学医院(AAUH)与豪克兰大学医院(HUH)2013—2017年因慢性硬膜下血肿接受手术的患者,埃塞俄比亚为前瞻性纳入,挪威为回顾性纳入。
- AAUH纳入314例,HUH纳入284例。
主要发现
- 中位年龄AAUH为60岁,HUH为75岁。
- 外伤史AAUH为72%,HUH为64.1%。
- 使用抗凝/抗血小板药物者HUH为45.1%,AAUH为3.2%;合并症HUH为77.5%,AAUH为30.3%。
- 术后CT扫描HUH为99.3%,AAUH为5.2%;再手术HUH为10.9%,AAUH为6.1%,两国再手术多因血肿复发。
- 内科并发症HUH为6.7%,AAUH为1.3%;1年死亡率HUH为7%,AAUH为3.5%;末次随访(>3年)GOSE 8分AAUH为82.9%,HUH为46.8%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 埃塞俄比亚为前瞻性纳入,挪威为回顾性纳入。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic subdural hematoma (CSDH) is one of the most common neurosurgical conditions. Here, we studied differences in demographics, treatment, and outcome for CSDH patients in low-income (Ethiopia) and high-income (Norway) countries and assessed potential outcome determinants. METHODS: We included patients from Addis Ababa University Hospitals (AAUH) and Haukeland University Hospital (HUH) who had surgery for CSDH (2013-2017). Patients were included prospectively in Ethiopia and retrospectively in Norway. RESULTS: We enrolled 314 patients from AAUH and 284 patients from HUH, with a median age of 60 and 75 years, respectively. Trauma history was more common in AAUH (72%) than in HUH patients (64.1%). More patients at HUH (45.1%) used anticoagulants/antiplatelets than at AAUH (3.2%). Comorbidities were more frequent in HUH (77.5%) than in AAUH patients (30.3%). Burr hole craniostomy under local anesthesia and postoperative drainage was the standard treatment in both countries. Postoperative CT scanning was more common at HUH (99.3%) than at AAUH (5.2%). Reoperations were more frequent at HUH (10.9%) than at AAUH (6.1%), and in both countries, mostly due to hematoma recurrence. Medical complications were more common at HUH (6.7%) than at AAUH (1.3%). The 1-year mortality rate at HUH was 7% and at AAUH 3.5%. At the end of follow-up (> 3 years), the Glasgow Outcome Scale Extended (GOSE) score was 8 in 82.9% of AAUH and 46.8% of HUH patients. CONCLUSION: The surgical treatment was similar at AAUH and HUH. The poorer outcome in Norway could largely be explained by age, comorbidity, medication, and complication rates.
引用
- Laeke T, Kalleklev L, Tirsit A, et al. Surgical treatment and outcome of chronic subdural hematoma: a comparative study between Ethiopia and Norway. Acta Neurochir (Wien). 2022. PMID: 36495322. doi:10.1007/s00701-022-05435-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。